News
1d
News-Medical.Net on MSNMany older adults take aspirin for heart disease prevention without doctor’s adviceAround 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease – despite stricter ...
Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease—despite stricter ...
New guidelines recommend aspirin use in primary prevention for people ages 40 to 70 years old who are at higher risk of a first cardiovascular event, but not for those over 70. Yet, people over 70 ...
Overall, the task force supported the use of aspirin for the primary prevention of coronary disease in patients whose five-year risk of disease was estimated to be 3 percent or higher, but it ...
The use of aspirin for the primary prevention of CVD continues to perplex the cardiology community, especially after the publication of three randomized controlled trials of aspirin in 2018 and a ...
Recently published trials offer more evidence to aid in physician decision-making regarding use of aspirin for primary prevention, according to a paper published in Annals of Internal Medicine ...
The members of our primary care roundtable discuss whether they would ever use a statin or aspirin for primary prevention. X. No Results. No Results. For You News & Perspective ...
"A review of the evidence for use of aspirin in primary prevention was last looked at 5 or 6 years ago but now we have additional data from three new trials published last year — ARRIVE in ...
Another primary-prevention subgroup that might benefit from aspirin includes patients with a coronary artery calcium (CAC) score > 100. Recently, Banach and colleagues drafted recommendations on the ...
If the rate of at-risk adults who took a daily aspirin increased to 90 percent, 45,000 lives could be saved every year, according to the National Commission on Prevention Priorities.
To TCTMD, Meyer said there remains some uncertainty about aspirin in primary prevention given that the per-protocol analysis from the ARRIVE trial—a study which included patients whose 10-year risk of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results